Printer Friendly

Articles from M2 Pharma (November 29, 2018)

1-22 out of 22 article(s)
Title Author Type Words
Astellas wins US FDA's approval for XOSPATA for treating adult AML patients with FLT3 Mutation. 297
Berkshire Sterile Manufacturing appoints Debbie Smith as new vice president of Quality Assurance. 126
Berkshire Sterile Manufacturing promotes Debbie Smith to VP of Quality Assurance. 156
Camurus' Buvidal Weekly and Buvidal Monthly (CAM2038) approved in Australia for treatment of opioid dependence. 288
Cardax names new chief clinical and regulatory strategist. 176
Catabasis Pharmaceuticals Publishes Phase 1 Clinical Results of Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy. 490
Encore Dermatology Releases Phase 2 Safety Data Demonstrating Lower Systemic Drug Exposure with Impoyz Cream, 0.025% Compared to Temovate Cream, 0.05%. 330
Generex Biotechnology Signs Clinical Trial Agreement with the NSABP Foundation for Phase II Clinical Trial of AE37 in Combination with Pembrolizumab for Treatment of Triple-Negative Breast Cancer. 433
Generex Biotechnology to acquire the medical device company Olaregen Therapeutix Inc. 283
Gutry Named Chief Business Officer at Kronos Bio to Expand Pipeline Opportunities. 328
MabVax Therapeutics Holdings enters into USD1.0m equity purchase agreement. 174
Novus Therapeutics Doses First Subjects in Phase 1 Study of OP0201. 306
Nuevolution improves negative result in Q3 2018. 113
Nuevolution reports exercise of opt-in right by Amgen in the second preclinical cancer programme under research collaboration. 218
Oasmia Pharmaceutical to convene extraordinary general meeting at the request of a large shareholder. 519
QPS expands phase one clinical trial capabilities. 270
Quest PharmaTech and OncoCare Therapeutics to develop targeted cancer therapy technology for pancreatic cancer in the US. 216
The US FDA approves the first treatment Firdapse for Lambert-Eaton myasthenic syndrome. 263
TRACON Pharmaceuticals partners with I-Mab Biopharma for multiple immuno-oncology programmes. 262
Vedanta Biosciences starts phase one clinical study of VE202. 146
ViaCyte to advance functional cures for insulin-requiring diabetes through new financings. 242
Zymeworks collaborates with BeiGene. 198

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters